U.S. Neovaginal Surgery Market Size & Outlook, 2023-2030
U.S. neovaginal surgery market, 2018-2030 (US$M)
Related Markets
U.S. neovaginal surgery market highlights
- The U.S. neovaginal surgery market generated a revenue of USD 202.4 million in 2023 and is expected to reach USD 275.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.5% from 2024 to 2030.
- In terms of segment, sex reassignment surgery was the largest revenue generating treatment type in 2023.
- Sex Reassignment Surgery is the most lucrative treatment type segment registering the fastest growth during the forecast period.
Neovaginal surgery market data book summary
| Market revenue in 2023 | USD 202.4 million |
| Market revenue in 2030 | USD 275.2 million |
| Growth rate | 4.5% (CAGR from 2023 to 2030) |
| Largest segment | Sex reassignment surgery |
| Fastest growing segment | Sex Reassignment Surgery |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Vaginal Agenesis Treatment Surgery, Sex Reassignment Surgery, Vaginal Atresia Treatment Surgery |
| Key market players worldwide | Icahn School of Medicine at Mount Sinai, Nationwide Children's Hospital, Tricity Institute of Plastic Surgery TIPS |
Other key industry trends
- In terms of revenue, U.S. accounted for 16.8% of the global neovaginal surgery market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. neovaginal surgery market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 27.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neovaginal Surgery Market Scope
Neovaginal Surgery Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. neovaginal surgery market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neovaginal surgery market will help companies and investors design strategic landscapes.
Sex reassignment surgery was the largest segment with a revenue share of 55.68% in 2023. Horizon Databook has segmented the U.S. neovaginal surgery market based on vaginal agenesis treatment surgery, sex reassignment surgery, vaginal atresia treatment surgery covering the revenue growth of each sub-segment from 2018 to 2030.
Strong presence of manufacturers of vaginal dilators in the country, resulting in ease of product availability for patients with vaginal anomalies is contributing to the market growth. Availability of hospitals and clinics, offering vaginal reconstruction treatment, such as Mount Sinai, Cedars-Sinai, Nationwide Children’s Hospital, and Ann & Robert H. Lurie Children's Hospital of Chicago, helps in promoting neovaginal surgery in the country.
Moreover, inclusion of vaginoplasty under insurance coverage by Medicare and private insurance providers boosts adoption of treatment for young girls with vaginal agenesis or atresia and transgender individuals.
Reasons to subscribe to U.S. neovaginal surgery market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. neovaginal surgery market databook
-
Our clientele includes a mix of neovaginal surgery market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. neovaginal surgery market , including forecasts for subscribers. This country databook contains high-level insights into U.S. neovaginal surgery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. neovaginal surgery market size, by treatment type, 2018-2030 (US$M)
U.S. Neovaginal Surgery Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
